Bajaj Finserv Healthcare Fund Direct Growth

Bajaj Finserv Healthcare Fund Direct Growth

NAV: 19 Nov '26
₹12.51
Min. for SIP
₹500
Fund size (AUM)
₹418.83 Cr
Expense ratio
0.90%
Rating
--

Return calculator

Monthly investment
₹5,000
Over the pastTotal investmentWould've becomeHistoric returnsReturns
3 months₹15,000₹15,423
+2.82%
6 months₹30,000₹32,054
+6.85%
1 year₹60,000₹70,125
+16.88%

Holdings (37)

NameSectorInstrumentsAssets
Divi's Laboratories LtdHealthcareEquity8.76%
Sun Pharmaceutical Industries LtdHealthcareEquity8.48%
Piramal Pharma LtdHealthcareEquity7.11%
Apollo Hospitals Enterprise LtdHealthcareEquity6.44%
Aurobindo Pharma LtdHealthcareEquity5.87%
Rubicon Research Ltd.HealthcareEquity5.84%
Laurus Labs LtdHealthcareEquity4.59%
Torrent Pharmaceuticals LtdHealthcareEquity4.44%
Dr. Reddy's Laboratories LtdHealthcareEquity3.96%
Emcure Pharmaceuticals Ltd.HealthcareEquity3.76%
Neuland Laboratories LtdHealthcareEquity3.41%
Zydus Lifesciences LtdHealthcareEquity2.93%
Alkem Laboratories LtdHealthcareEquity2.84%
Max Healthcare Institute LtdHealthcareEquity2.68%
Ipca Laboratories LtdHealthcareEquity2.32%
Fortis Healthcare LtdHealthcareEquity2.20%
Vijaya Diagnostic Centre LtdHealthcareEquity2.13%
Net ReceivablesUnspecifiedNet Receivables2.07%
Zydus Wellness LtdConsumer StaplesEquity1.92%
Shaily Engineering Plastics LtdMaterialsEquity1.88%
Senores Pharmaceuticals Ltd.HealthcareEquity1.65%
Dr. Lal Pathlabs LtdHealthcareEquity1.60%
Glenmark Pharmaceuticals LtdHealthcareEquity1.52%
Glaxosmithkline Pharmaceuticals LtdHealthcareEquity1.42%
Cipla LtdHealthcareEquity1.32%
Bajaj Finserv Money Market Fund Direct-GrowthUnspecifiedMutual Fund1.27%
Others CBLOUnspecifiedCBLO1.26%
Sanofi Consumer Healthcare India LtdHealthcareEquity1.14%
Navin Fluorine International LtdMaterialsEquity0.96%
Biocon LtdHealthcareEquity0.96%
Krishna Institute Of Medical Sciences LtdHealthcareEquity0.84%
Onesource Specialty Pharma LtdHealthcareEquity0.82%
Jubilant Pharmova LtdHealthcareEquity0.77%
Medi Assist Healthcare Services Ltd.IndustrialsEquity0.47%
Neogen Chemicals LtdMaterialsEquity0.20%
Sumitomo Chemical India LtdMaterialsEquity0.15%
NIFTY 23500 Call November 2026 OptionFinancialIndex Derivatives0.02%

Minimum investments

Min. for 1st investment
₹500
Min. for 2nd investment
₹100
Min. for SIP
₹500

Returns and rankings

Name3M6M1YAll
Fund returns+3.6%+17.0%+24.2%+25.1%
Category average (Equity Sectoral)+3.6%+12.1%+20.9%+198.9%
Rank (Equity Sectoral)1338--

Exit load, stamp duty and tax

Exit load

1% for redemption within 3 Months

Stamp duty on investment: 0.005% (from July 1st, 2020)

from July 1st 2020

Tax implication

If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.

Fund management

Education
Mr. Gupta is a B.Com, CA and CFA.
Experience
Prior to joining Bajaj Finserv Mutual Fund, he was associated with Quantum Mutual Fund, Siddhesh Capital Markets Pvt. Ltd. & Pranav Securities Pvt. Ltd. He has over 11 years of overall experience in the equity research.

Education
B.E (Information Science), PGDM (Finance) and CFA.
Experience
Prior to joining the Bajaj Finserv AMC, he was associated with Bharti AXA Life Insurance Company Limited, Motilal Oswal Financial Services Limited, SBICAP Securities Limited, and CRISIL Global Research & Analytics.

About Bajaj Finserv Healthcare Fund Direct Growth

Bajaj Finserv Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Bajaj Finserv Mutual Fund. This scheme was made available to investors on 18 Oct 2021. Siddharth Chaudhary is the Current Fund Manager of Bajaj Finserv Healthcare Fund Direct Growth fund. The fund currently has an Asset Under Management(AUM) of ₹38,228 Cr and the Latest NAV as of 19 Nov 2026 is ₹12.51. The Bajaj Finserv Healthcare Fund Direct Growth is rated Very High risk. Minimum SIP Investment is set to ₹500. Minimum Lumpsum Investment is ₹500. 1% for redemption within 3 Months ;

Investment Objective

The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
Fund benchmarkBSE Healthcare Total Return Index

Fund house

Rank (total assets)--
Total AUM₹38,228.00 Cr
Date of Incorporation18 Oct 2021
Phone--
E-mail--
Launch Date18 Oct 2021
AddressS. No - 239/2, 11th Floor, Office No. 1101 A and 1101 B,Sky One Corporate Park, Lohegaon, Pune, Maharashtra Pune 411032
CustodianDeutsche Bank
Registrar & Transfer AgentKFin Tech
AddressKarvy House, No. 46, 8-2-609/K, Avenue 4, Street No.1 Banjara Hills,